Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with hormone-dependent cancer. Co.'s business is dependent on the development, regulatory approval and commercialization of its therapeutic product candidates, ONA-XR and CLDN6xCD3 bsAb, which are in the early stages of development. We show 9 historical shares outstanding datapoints in our CNTX shares outstanding history coverage, used to compute CNTX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CNTX market cap history over the course of time is important for investors
interested in comparing CNTX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CNTX versus a peer is one thing; comparing
CNTX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CNTX can fluctuate over the course of history.
With this page we aim to empower investors researching CNTX by allowing them to research the CNTX market cap history. |
Free CNTX Email Alerts:
Video: The Importance of Market Cap
